Article
Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Dec 2008
Kim Hong-Tae, Lee Jong-Eun, Shin Eun-Soon, Yoo Yeon-Kyeong, Cho Jae-Hwa, Yun Min-Hye, Kim Yeul-Hong, Kim Se-Kyu, Kim Hyun-Jung, Jang Tae-Won, Kwak Seung-Min, Kim Chul-Soo, Ryu Jeong-Seon
Abstract excerpt
PURPOSE: To determine whether germ-line variations in BRCA1 affect outcome in non-small-cell lung cancer (NSCLC) patients treated with platinum combination chemotherapy. PATIENTS AND METHODS: We evaluated the associations of four tagging BRCA1 polymorphisms and their haplotypes with treatment outcome in 300 NSCLC patients at stages IIIA (16%), IIIB (31%), and IV (53%). RESULTS: The median age was 63 years (range,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
